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ABSTRACT  
Purpose 
Pyogenic spondylodiscitis (PS) is still burdened by a high rate of orthopedic and neurological 
complications. Despite the rising incidence, the choice of a proper orthopedic treatment is often 
delayed by the lack of clinical data. The aim of this study was to propose a clinical-radiological 
classification of pyogenic spondylodiscitis to define a standard treatment algorithm. 
Methods 
Based on data from 250 patients treated from 2008 to 2015, a clinical-radiological classification of 
pyogenic spondylodiscitis was developed. According to primary classification criteria (bone 
destruction or segmental instability, epidural abscesses and neurological impairment), three main 
classes were identified. Subclasses were defined according to secondary criteria. PS without 
segmental instability or neurological impairment were treated conservatively. When significant 
bone loss or neurological impairment occurred, surgical stabilization and/or decompression were 
performed. All patients underwent clinical and radiological two-year follow-up. 
Results 
Type A PS occurred in 84 patients, while 46 cases were classified as type B and 120 as type C. 
Average time of hospitalization was 51.94 days and overall healing rate was 92.80%. 140 patients 
(56.00%) were treated conservatively with average time of immobilization of 218.17±9.89 days. 
Both VAS and SF-12 scores improved across time points in all classes. Residual chronic back pain 
occurred in 27 patients (10.80%). Overall observed mortality was 4.80%. 
Conclusions 
Standardized treatment of PS is highly recommended to ensure patients a good quality of life. The 
proposed scheme includes all available orthopedic treatments and helps spine surgeons to 
significantly reduce complications and costs and to avoid overtreatment. 
 
 
 
 
 
INTRODUCTION 
Pyogenic spondylodiscitis (PS) is a potentially life-threating infectious disease involving the 
intervertebral disc and adjacent vertebral bodies. Previous studies estimated the annual incidence of 
pyogenic spondylodiscitis ranging from 0,4 to 2,4/100000 inhabitants in Europe [1,2]. The 
variability of available data about incidence depends on the inclusion criteria and statistical methods 
of the few existing studies covering limited geographical areas. PS occurs predominantly in elderly 
and chronically debilitated patients aged over 50 years and is more common in male patients, with a 
male to female ratio of 1,5-2:1 [1,3,4]. Pyogenic spondylodiscitis has always been considered a rare 
condition in Europe according to the few epidemiological reports available in the past. However, 
several recent studies reported an alarming increase of incidence in Europe in the last 20 years. A 
Danish 14-year population-based study showed that overall incidence of PS increased 2,2-5,8 cases 
per 100000 person years [5]. Aging population and longer life expectancy of patients affected by 
chronic debilitating diseases and immunodeficiency led to an increased number of high-risk 
individuals, while the spread of invasive and minimally invasive diagnostic and surgical procedures 
exposed more patients to iatrogenic infections. The increase of incidence is also due to the higher 
diagnostic efficacy obtained with the spread of MRI. Estimated mortality is highly variable 
depending on geographical areas with reported peaks up to 11% [6-10]. 
Etiology and infection routes 
According to etiology, pyogenic or non-specific spondylodiscitis can be differentiated into bacterial, 
fungal or parasitic infections. Among bacterial PS, Staphylococcus aureus is the most frequent 
causative microorganism accounting for half of the cases, while fungal and parasitic forms represent 
less than 2% of all cases [6]. PS is in most cases a hematogenous infection due to septic 
dissemination from distant infectious foci. The development of PS by direct inoculation is less 
common than hematogenous spread and can occur following spinal surgery, epidural procedures 
and lumbar puncture with a reported prevalence up to 18,8% [11]. Through the osteonecrosis, the 
infection can spread to paravertebral soft tissues and epidural space producing abscesses and 
leading to biomechanical instability and neurological impairment in about 1/3 of all cases [3,6,7]. 
Treatment goals 
Treatment of pyogenic spondylodiscitis is a story of great successes which led from the mortality 
rate of about 70% observed by Kulowski in 1936 to nowadays optimal clinical outcomes [12]. First 
aim of the treatment strategy should be to eradicate the infection and prevent sepsis. However, 
while the antibiotic therapy greatly reduced mortality, PS is still burdened by a high rate of 
orthopedic and neurological complications with great impact on patients’ quality of life [9,10]. The 
goals of orthopedic treatment are to preserve or establish spinal stability, relieve pain, prevent or 
reverse neurological deficits and prevent recurrence [13, 16-18].  
Practical guidelines for the pharmacological management of PS have been proposed by the 
Infectious Diseases Society of America (IDSA) in 2015 [19]. On the other hand, the lack of large 
clinical studies and the variability of inclusion criteria of existing clinical series still hinder the 
development of a standard algorithm for orthopedic treatment.  
Aim of this study is to propose a new classification of pyogenic spondylodiscitis based on clinical 
and radiological features to define a simple and reproducible treatment algorithm for spine surgeons.   
 
MATERIALS AND METHODS 
Based on data from 250 patients treated at our University Hospital from 2008 to 2015 with a two-
year follow-up, a clinical-radiological classification of pyogenic spondylodiscitis was developed. 
Both spine surgeons and infectious diseases specialists were involved in caring of all the patients 
establishing a multidisciplinary clinical management. Diagnostic approach included accurate 
anamnesis and physical examination, serial C-reactive protein (CRP), erythrocyte sedimentation 
rate (ESR), complete blood count, and full spine contrast-enhanced MRI (or CT when 
contraindicated). Blood cultures were collected from all patients after adequate antibiotics 
interruption and just before and after every invasive procedure. Patients with negative blood 
cultures underwent CT-guided biopsy, while surgical transpedicular biopsy was used as third line 
isolation technique [13].  
All patients received antibiotics intravenous therapy for at least 4 weeks followed by oral course 
until normalization of radiological and laboratory markers of infection [19]. Patients without 
etiological diagnosis even after surgical biopsy, received empiric broad-spectrum antibiotic therapy 
and underwent closer blood tests monitoring [19]. Conservative orthopedic treatment consisted of 
24/7 immobilization with rigid orthosis until complete infection healing. Rigid orthosis consisted on 
hard cervical collar with proper chin support, or thoraco-lumbar rigid brace molded on plaster cast 
to avoid kyphosis. Posterior percutaneous screw-rod instrumentation bridging the infected level was 
used as alternative minimally invasive approach to orthosis in patients with single-level thoraco-
lumbar PS and high functional demand. Open surgical treatment included debridement of necrotic 
tissues, decompression of neurological structures and spine instrumentation, avoiding infected 
vertebral bodies, through anterior or posterior approaches. The same orthopedic treatments were 
used in patients without microbiological diagnosis.           
Physical examination, serial blood tests and targeted MRI were performed at 1,3,6,12 and 24 
months from diagnosis. At each follow-up visit, patients were also asked to fill in Visual Analogic 
Scale (VAS) and Short-Form 12 (SF-12) questionnaires.  
Classification criteria 
Classification criteria were selected among clinical and radiological factors with known prognostic 
value. Three main types (A, B and C) were defined depending on to the following primary criteria: 
bone destruction or segmental instability, epidural abscesses and neurological impairment (Table 1). 
Secondary criteria were: involvement of paravertebral soft tissues and intramuscular abscesses 
(Table 1). Biomechanical instability was defined as more than 25% change of segmental kyphosis 
at the infection level. Accurate physical examination including evaluation of deep tendon reflexes, 
sensibility, muscle strength and central pathological signs, was performed to exclude neurological 
impairment. Contrast-enhanced MRI was used to evaluate neurological structures, abscesses and 
involvement of paravertebral soft tissues.  
Type A 
All cases without biomechanical instability neither acute neurological impairment or epidural 
abscesses were included (Fig. 1). Depending on secondary criteria, subclasses were defined as 
follow: 
 A.1: simple discitis without involvement of vertebral bodies (Fig. 1a).  
 A.2: spondylodiscitis involving the intervertebral disc and adjacent vertebral bodies (Fig. 
1b). 
 A.3: spondylodiscitis with limited involvement of paravertebral soft tissues (Fig. 1c). 
 A.4: spondylodiscitis with unilateral (A.4.1) or bilateral (A.4.2) intramuscular abscesses 
(Fig. 1d). 
Treatment of choice was 24/7 rigid orthosis immobilization until complete infection healing (Table 
2). Patients with higher functional demand underwent minimally invasive posterior percutaneous 
stabilization (Table 2). 
Type B 
All cases with radiological evidence of significant bone destruction or biomechanical instability 
without acute neurological impairment or epidural abscesses were included (Fig. 2). Patients were 
treated according to the following subclasses: 
 B.1: destructive spondylodiscitis without segmental instability (Fig. 2a).  
 B.2: destructive spondylodiscitis extended to paravertebral soft tissues without segmental 
instability (fig. 2b). 
 B.3: destructive spondylodiscitis with biomechanical instability and segmental kyphosis 
(B.3.1<25°; B.3.2>25°) (Fig. 2c). 
Conservative treatment or percutaneous stabilization were indicated for destructive PS with 
preserved spine stability (B.1 and B.2) (Table 2). When segmental kyphosis or instability occurred 
(B.3), surgical stabilization was always performed (Table 2). Minimally invasive posterior 
percutaneous approach was considered an option to treat patients with mild kyphosis (B.3.1). 
Type C 
All cases with epidural abscesses or acute neurological impairment were included (Fig. 3).  
 C.1: epidural abscess without neurological symptoms neither segmental instability (Fig. 3a). 
 C.2: epidural abscess and segmental instability without neurological impairment (Fig. 3b). 
 C.3: epidural abscess and acute neurological impairment without segmental instability (Fig. 
3c). 
 C.4: epidural abscess and acute neurological impairment with segmental instability (Fig. 3d). 
Patients without acute neurological symptoms and segmental instability (C.1) were treated 
conservatively and closely monitored to evaluate neurological anomalies (Table 2). Type C.2 
spondylodiscitis were treated with surgical stabilization and abscess debridement to avoid 
impending neurological damages (Table 2). When neurological impairment occurred (C.3 and C.4), 
surgical decompression of neurological structures was always performed, combined with segmental 
stabilization in the same procedure if biomechanical stability was jeopardized (Table 2).  
Statistical analysis  
Baseline demographic and clinical onset characteristics were assessed using independent-sample t 
tests for continuous variables and χ2 tests for frequency variables. Analysis of variance was used to 
assess differences in clinical outcomes across follow-up, and p values .05 or less were considered 
significant. Continuous variables are presented as mean ± standard error. Frequency data are 
presented as counts and percentages. Epi Info statistic software, version 7 (CDC, Atlanta, GA, 
USA), was used for data analysis. 
 
 
RESULTS 
A total of 250 patients (161 men and 89 women) were treated at our University Hospital from 
January 2008 to January 2015. Average age was 64.98±0.97, moreover age distribution showed a 
significant peak in the 60-75 years of age group. Average diagnostic delay was 49.90±5.53 days 
from symptoms onset. Most common symptoms at diagnosis were localized spinal pain (236 
patients; 94.40%; 95%CI [89.68-97.21]) and fever (159 patients; 63.60%; 95%CI [55.80-70.97]). 
Limbs radiating pain and weight loss were referred less frequently (106 patients; 42.40%; 95%CI 
[35.04-50.43] and 84 patients; 26.30%; 95%CI [26.30-41.40]). 56 patients presented with 
neurological deficits at diagnosis (22.40%; 95%CI [16.43-29.53]) (Fig. 4). Lumbar spine was the 
most commonly affected (184 patients; 73.60%; 95%CI [66.29-80.16]) with peaks at L3-L5 levels. 
Other frequently involved levels were C5-C6 for cervical spine and D8-D10 for thoracic spine. No 
localizations were observed at C0-C3 levels.  
Etiological diagnosis was assessed in about ¾ of all patients (190 patients; 76.00%; 95%CI [68.91-
82.21]). Observed sensibility of blood culture, CT-guided biopsy and surgical biopsy was 57,64% 
(95%CI [49,13-65,82]), 46,27% (95%CI [34,00-58,88]) and 60,00% (95%CI [44,33-74,30]) 
respectively. Staphylococcus aureus was the most frequently isolated causative agent (70 patients; 
28.00%; 95%CI [20.97-36.11]). Other commonly isolated microorganism were Staphylococcus 
epidermidis, Escherichia coli, and Klebsiella pneumoniae. 12 patients (4.80%; 95%CI [1.95-9.63]) 
were infected by Methicillin-resistant Staphylococcus aureus (MRSA). 19 patients (7.60%; 95%CI 
[3.75-13.69]) had polymicrobial infections (Table 3).   
62 patients developed PS after surgical procedures (24.80%; 95%CI [18.61-31.98]). Direct 
inoculation of causative agents during spine invasive procedures occurred in 45 patients (18.00%; 
95%CI [12.51-24.46]).  
Type A spondylodiscitis occurred in 84 cases (33.60%). Types A.1 and A.2 included 11 (13.09%) 
and 28 (33.33%) patients respectively. Paravertebral abscesses (type A.3) were reported in 33 
patients (39.29%), whereas intramuscular abscesses (type A.4) occurred in 12 patients (14.29%). 
Among type A cases, 74 patients (88.10%) were prescribed 24/7 rigid orthosis immobilization, 
whereas 10 patients (11.90%) underwent posterior percutaneous stabilization.  
46 cases (18.40%) were classified as type B destructive spondylodiscitis. Segmental stability was 
preserved (types B.1 and B.2) in 17 cases (36.96%). 29 patients (63.04%) presented segmental 
instability (type B.3) and 20 of them needed open surgical fixation, whereas 9 patients underwent 
percutaneous stabilization.  
120 cases (48.00%) were classified as type C spondylodiscitis with epidural abscesses or 
neurological impairment. Among type C cases, 49 patients (40.83%) had no neurological deficits 
neither segmental instability (type C.1), thus they were treated conservatively. Type C.2 included 
15 patients (12.50%) that underwent surgical stabilization and abscess debridement. 30 patients 
(25.00%) with acute neurological deficits without segmental instability (type C.3) underwent 
surgical decompression of neurological structures. Open surgical stabilization was combined in the 
same procedure (type C.4) in 26 cases (21.67%).    
Average time of hospitalization was 51.94±3.00 days. Full healing from infection was achieved in 
232 patients with an overall healing rate of 92.80% (95%CI [87.17-96.49]). 14 relapses have been 
reported during follow-up with an overall recurrence rate of 5.60% (95%CI [2.67-10.67]).  
Clinical outcomes for each class are shown in Table 4. A total of 140 patients (56.00%) were 
treated conservatively. Average time of rigid orthosis immobilization was 218.17±9.89 days. 
Among 110 cases (44.00%) treated surgically, 4 patients underwent procedure-related 
complications, however none of them reported permanent damages. 
Self-reported VAS scores consistently decreased across time points in all classes reaching an 
average value of .65±.21 at two years from diagnosis (Fig. 5). Similarly, mental and physical 
components of SF-12 questionnaire increased significantly (Fig. 6).  
Residual chronic back pain occurred in 27 patients (10.80%), whereas 13 patients (5.20%) showed 
residual neurological deficits. Overall mortality was 4.80% (95%CI [3.33-6.48]). 
 
DISCUSSION 
Despite considerably improved diagnostic efficiency, there are no standardized orthopedic 
treatment guidelines for pyogenic spondylodiscitis due to heterogeneous clinical data available in 
literature, often based on small patient populations [18]. Actually, few standardized treatments are 
suggested but without prospective randomized controlled trials the level of evidence for treatment 
recommendations remains low [20]. Therefore, a classification of PS based on clinical and 
radiological features with a standard treatment algorithm can be very useful to spine surgeons 
facing this pathology.   
Clinical onset of pyogenic spondylodiscitis is typically nonspecific and paucisymptomatic. Thus, 
differential diagnosis with degenerative spine pathologies is often difficult. Different reviews 
reported a mean diagnostic delay of 90 days [6,7]. For this reason, early diagnosis should be the 
first aim of clinical approach to PS. Early diagnosis is based on a high level of suspicion with 
emphasis on patients presenting acute and localized spinal pain combined with fever and known 
risk factors for infectious diseases. About 1/3 of all patients can be apyretic at clinical onset 
hindering the differential diagnosis with non-infectious spine pathologies. Contrast-enhanced MRI 
showed the highest diagnostic sensibility and provides a baseline picture on biomechanical stability 
and neurological structures [21,22]. When MRI is promptly performed, impending neurological 
lesions or structural damages can be detected earlier allowing the choice of less invasive treatments. 
CT may be useful when there are doubts on osteonecrosis extension or biomechanical stability. 
There are no pathognomonic laboratory markers but CRP, ESR and WBC anomalies should raise 
the level of suspicious.  
The high healing rate and low recurrence rate observed in this study firstly demonstrate that a 
multidisciplinary approach to PS is the best choice. Early administration of specific antibiotics 
prevents further damages and diffusion of causative agent. While waiting for the microbiological 
results, an empirical therapy can be started in severe cases [19]. According to 2015 IDAS guidelines, 
intravenous therapy should be administrated for at least 4 weeks followed by oral course until 
normalization of laboratory and radiological markers of infection [19]. On the other hand, surgical 
debridement may be necessary to eradicate the infection [9,10]. The high efficiency of 
microbiological isolation techniques observed in this study (76.00%) also derives from the close 
collaboration with infectious diseases specialists. In fact, blood culture when adequately collected, 
especially before and after invasive procedures, showed higher sensibility then reported in literature 
data. 55 patients (22.00%) needed surgical biopsy.    
When there are no neurological deficits and no significant instability, PS can be managed without 
surgical intervention (types A.1-4, B.1-2 and C.1). Lumbar epidural abscess may be approached 
with a conservative treatment only if there is no evidence for cauda equina or conus dysfunction 
[9,14]. Immobilization is necessary to maintain spinal stability until bony ankylosis occurs [9,10]. 
However, spontaneous ankylosis requires 6 to 24 months and may not take place at all [23]. In our 
population, average time of immobilization was about 7 months. Residual chronic back pain 
observed in 10.80% of our patients is mostly attributable to non-surgically treated patients with 
postinfection kyphosis or pseudoarthrosis.  
Since January 2010, percutaneous posterior screw-rod instrumentation bridging the infected level 
has been used as safe and effective alternative approach to prolonged rigid bracing for single-level 
thoraco-lumbar PS. A retrospective cohort study demonstrated faster recovery and improved quality 
of life associated with minimally invasive treatment [24]. Posterior percutaneous stabilization is 
also indicated in patients with biomechanical instability and mild segmental kyphosis (type B.3.1).  
When acute neurological impairment or severe kyphosis occur (types B.3.2, C.3-4), open surgical 
approach is mandatory. Emergency decompression is indicated if complete plegia develops [18]. 
Decompression and instrumented spinal stabilization should be performed in the same procedure if 
neurological deficit exists (type C.4). On the contrary, if instability and pain are present in a patient 
without neurological impairment (types B.3 and C.2), correction of deformity through 
instrumentation may be delayed until infection has been cleared [14,25]. Debridement and 
arthrodesis may be sufficient in cases without instability (type C.3), combined with bed rest and 
bracing [19,27]. When the bone loss created by debridement leads to potential instability, surgical 
reconstruction through interbody fusion or posterior stabilization is necessary [23].    
The choice of surgical techniques and appropriate approaches and instrumentation to treat PS is still 
a matter of controversy. Pyogenic infections predominantly involve the vascularized vertebral body 
with involvement of the posterior elements in only 5% of the cases [27]. Thus, anterior surgical 
approach is most often used when aggressive debridement is indicated. The gold standard for 
anterior column reconstruction is the use of structural bone auto- or allografting [25,26]. An 
effective alternative to structural bone autograft is the titanium mesh or PEEK cage. When cage is 
combined with anterior and/or posterior instrumentation in a single stage procedure, this technique 
ensures immediate stability [17,26,28,29].   
Observed surgical complication rate was very low with no permanent disability. Among 56 patients 
with neurological deficits at diagnosis, reverse of neurological deficits was achieved in 43 cases 
(76.79%).  
Improvement in VAS and SF-12 scores across time points demonstrate that an adequate treatment 
algorithm ensures effective pain relief and good quality of life.   
In conclusion, standardized treatment of pyogenic spondylodiscitis based on clinical-radiological 
classification is highly recommended. The proposed scheme includes all available orthopedic 
treatments and helps spine surgeons to significantly reduce complications and avoid overtreatment. 
The use of a common language to treat pyogenic spondylodiscitis allows shorter hospitalization 
with reduced costs. This simple and reproducible scheme is suitable also for spine surgeons with 
less experience in treating PS.    
  
 
 
 
 
 
 
TABLES AND FIGURES 
 
Table 1 Classification scheme according to primary and secondary criteria  
Classes Bone 
destruction 
Segmental 
instability  
Epidural  
abscess 
Neurological  
impairment 
Paravertebral 
involvement 
Type A 
 
A.1 
A.2 
A.3 
A.4.1-2 
No 
 
No 
No 
No 
No 
No 
 
No 
No 
No 
No 
No 
 
No 
No 
No 
No 
No 
 
No 
No 
No 
No 
Yes/No 
 
No (simple discitis) 
No 
Yes 
Yes (muscle abscess) 
Type B 
 
B.1 
B.2 
B.3.1-2 
Yes 
 
Yes 
Yes 
Yes 
Yes/No 
 
No 
No 
Yes 
No 
 
No 
No 
No 
No 
 
No 
No 
No 
Yes/No 
 
No 
Yes 
Yes 
Type C 
 
C.1 
C.2 
C.3 
C.4 
Yes/No 
 
Yes/No 
Yes 
Yes 
Yes 
Yes/No 
 
No 
Yes 
No 
Yes 
Yes 
 
Yes 
Yes 
Yes 
Yes 
Yes/No 
 
No 
No 
Yes 
Yes 
- 
 
- 
- 
- 
- 
 
Table 2 Treatment algorithm showing the treatments of choice according to the classification scheme 
Classes Treatments of choice 
 
Type A 
A.1 
A.2 
A.3 
A.4.1-2 
 
Rigid orthosis immobilization 
Rigid orthosis immobilization or percutaneous stabilization 
Rigid orthosis immobilization or percutaneous stabilization 
Rigid orthosis immobilization or percutaneous stabilization 
Type B 
B.1 
B.2 
B.3.1-2 
 
Rigid orthosis immobilization or percutaneous stabilization 
Rigid orthosis immobilization or percutaneous stabilization  
Percutaneous or open stabilization 
Type C 
C.1 
 
C.2 
C.3 
C.4 
 
Rigid orthosis immobilization or percutaneous stabilization with closer clinical-
radiological monitoring 
Open debridement and stabilization 
Open debridement and decompression  
Open debridement, decompression and stabilization 
 
 
 
Table 3 Causative agents cultured from blood and/or tissue specimens in overall population 
Causative agents Prevalence  
n (%) 
Staphylococcus aureus 70 (28.00) 
Staphylococcus epidermidis 36 (14.40) 
Escherichia coli 17 (6.80) 
Klebsiella pneumoniae 14 (5.60) 
MRSA 12 (4.80) 
Polymicrobial 19 (7.60) 
 
 
 
Table 4 Clinical outcomes observed at two-year follow-up for each type of PS  
Clinical outcomes Type A 
(n=84) 
Type B 
(n=46) 
Type C 
(n=120) 
Prevalence  
n (%) 
 
84 (33.60) 
 
46 (18.40) 
 
120 (48.00) 
Healing rate  
n (%) 
 
81 (96.43) 
 
43 (93.48) 
 
108 (90.00) 
Residual chronic pain  
n (%) 
 
9 (10.71) 
 
5 (10.87) 
 
13 (10.83) 
Recurrence rate  
n (%) 
 
8 (9.52) 
 
2 (4.35) 
 
4 (3.33) 
Mortality  
n (%) 
 
3 (3.57) 
 
3 (6.52) 
 
6 (5.00) 
 
Figure Legends  
Figure 1 Magnetic resonance imaging (MRI) of type A pyogenic spondylodiscitis (PS). (a) Sagittal 
T1-weighted and axial T2-weighted MRI showing type A.1. post-operative L4-L5 discitis. (b) 
Sagittal T1-weighted and axial T2-weighted MRI of type A.2. PS with involvement of both L4 and 
L5 vertebral bodies. (c) Sagittal and coronal T1-weighted contrast-enhanced MRI showing type A.3. 
PS involving D7-D8 vertebral bodies with paravertebral abscess (arrows). (d) Coronal and axial 
contrast-enhanced MRI showing type A.4.2. PS with bilateral intra-psoas abscesses (arrows) 
Figure 2 MRI of type B destructive pyogenic spondylodiscitis (PS). (a) Sagittal T1-weighted and 
axial T2-weighted MRI showing type B.1 PS with partial destruction of L3 vertebral body. (b) 
Sagittal and coronal contrast-enhanced MRI of type B.2 destructive PS involving L4 and L5 
vertebral bodies with paravertebral abscess (arrows). (c) Sagittal and axial T2-weighted MRI 
showing type B.3 thoracic PS with 46.71° kyphosis.  
Figure 3 MRI of type C pyogenic spondylodiscitis (PS). (a) Sagittal contrast-enhanced MRI and 
axial T2-weighted MRI of type C.1 lumbar PS with limited epidural abscess. Sagittal and axial T2-
weighted MRI showing type C.2 lumbar PS with limited epidural abscess (arrows) and significant 
bone destruction. (c) Sagittal and axial contrast-enhanced MRI showing type C.3 lumbar PS with 
extended epidural abscess (arrows) in a 53-year-old male patient presented with acute cauda equina 
syndrome. (d) Sagittal and axial T2-weighted MRI of type C.4 thoracic PS in a 68-year-old female 
patient presented with acute paraplegia  
Figure 4 Frequency of most common onset symptoms observed at diagnosis in overall population 
Figure 5 Self-reported Visual Analog Scale (VAS) scores are shown at diagnosis and at 1,3,6,12, 
and 24 months post-diagnosis. VAS scores significantly decreased in all classes across time points 
showing the efficacy of the proposed treatment algorithm in controlling pain 
Figure 6 Pre- and post-treatment short-form (SF-12) mental component (left) and physical 
component (right) scores are shown at 1,3,6,12, and 24 months after diagnosis. Both scores 
significantly increased in all classes across follow-up demonstrating a good restoration of patients’ 
quality of life 
 
 
 
 
Figure 7 Magnetic resonance imaging (MRI) of type A pyogenic spondylodiscitis (PS). (a) Sagittal T1-
weighted and axial T2-weighted MRI showing type A.1. post-operative L4-L5 discitis. (b) Sagittal T1-
weighted and axial T2-weighted MRI of type A.2. PS with involvement of both L4 and L5 vertebral bodies. 
(c) Sagittal and coronal T1-weighted contrast-enhanced MRI showing type A.3. PS involving D7-D8 vertebral 
bodies with paravertebral abscess (arrows). (d) Coronal and axial contrast-enhanced MRI showing type 
A.4.2. PS with bilateral intra-psoas abscesses (arrows) 
 
 Figure 8 MRI of type B destructive pyogenic spondylodiscitis (PS). (a) Sagittal T1-weighted and axial T2-
weighted MRI showing type B.1 PS with partial destruction of L3 vertebral body. (b) Sagittal and coronal 
contrast-enhanced MRI of type B.2 destructive PS involving L4 and L5 vertebral bodies with paravertebral 
abscess (arrows). (c) Sagittal and axial T2-weighted MRI showing type B.3 thoracic PS with 46.71° kyphosis.  
 
 
Figure 9 MRI of type C pyogenic spondylodiscitis (PS). (a) Sagittal contrast-enhanced MRI and axial T2-
weighted MRI of type C.1 lumbar PS with limited epidural abscess. Sagittal and axial T2-weighted MRI 
showing type C.2 lumbar PS with limited epidural abscess (arrows) and significant bone destruction. (c) 
Sagittal and axial contrast-enhanced MRI showing type C.3 lumbar PS with extended epidural abscess 
(arrows) in a 53-year-old male patient presented with acute cauda equina syndrome. (d) Sagittal and axial 
T2-weighted MRI of type C.4 thoracic PS in a 68-year-old female patient presented with acute paraplegia  
 Figure 10 Frequency of most common onset symptoms observed at diagnosis in overall population 
 
 
 
 
Figure 11 Self-reported Visual Analog Scale (VAS) scores are shown at diagnosis and at 1,3,6,12, and 24 
months post-diagnosis. VAS scores significantly decreased in all classes across time points showing the 
efficacy of the proposed treatment algorithm in controlling pain  
 
 Figure 12 Pre- and post-treatment short-form (SF-12) mental component (left) and physical component 
(right) scores are shown at 1,3,6,12, and 24 months after diagnosis. Both scores significantly increased in all 
classes across follow-up demonstrating a good restoration of patients’ quality of life 
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